发明名称 1,4-DI-SUBSTITUTED IMIDAZOLE DERIVATIVE
摘要 The present invention provides: a 1,4-di-substituted imidazole derivative that is represented by formula (1'), that shows excellent cancer cell sphere forming ability suppressing effect, and that is useful as an orally administrable antitumor agent; and a pharmaceutically acceptable salt thereof. [In the formula, ring Q1 represents an optionally substituted C6-10 aryl group or the like, R1 and R2 independently represent a hydrogen atom or the like, W1 represents an optionally substituted C1-4 alkylene group, W2 represents -NR3aC(O)- or the like (wherein, R3a represents a hydrogen atom or a C1-6 alkyl group); ring Q2 represents a 5-10 membered heteroaryl group; W3 represents an optionally substituted C1-4 alkylene group or the like; n represents 1, 2, 3, 4, or 5; R4 represents, independently when more than one thereof exists, a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like; and R5 represents a hydroxy group or the like.]
申请公布号 WO2016208591(A1) 申请公布日期 2016.12.29
申请号 WO2016JP68423 申请日期 2016.06.21
申请人 SUMITOMO DAINIPPON PHARMA CO., LTD. 发明人 BAN, Hitoshi;WATANABE, Manabu;TOJO, Shingo;HASEGAWA, Futoshi;HASHIZUME, Miki
分类号 C07D401/12;A61K31/422;A61K31/427;A61K31/4439;A61K31/4709;A61K31/497;A61K45/00;A61P35/00;A61P35/02;A61P43/00;C07D403/12;C07D413/12;C07D417/12 主分类号 C07D401/12
代理机构 代理人
主权项
地址